Braxia Scientific Corp.
BRAXF
$0.001
-$0.0002-16.67%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -227.78% | 65.94% | 89.45% | -254.02% | 10.98% |
| Total Depreciation and Amortization | -0.73% | 30.86% | -65.11% | -14.37% | 0.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.78% | 123.53% | -99.70% | 3,437.45% | -116.44% |
| Change in Net Operating Assets | 5,557.14% | -102.85% | -77.25% | 147.56% | -149.11% |
| Cash from Operations | -211.62% | 70.14% | 56.81% | 64.12% | -97.02% |
| Capital Expenditure | -- | 100.00% | 96.87% | -9.12% | 90.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 299.01% | -140.89% | -66.49% | 131.62% |
| Cash from Investing | -133.33% | 279.46% | 17.65% | -135.32% | 106.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -437.97% | 44.37% | -57.78% | -42.86% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -428.81% | 44.34% | -101.14% | 20,276.09% | 4.17% |
| Foreign Exchange rate Adjustments | 223.53% | 64.58% | -112.90% | 214.11% | -161.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -277.81% | 74.71% | -1,896.88% | 99.17% | -41.49% |
